Crude extracts prepared from the plant tumor inducing organism Agrobacterium tumefaciens were shown to convert uracil and D-ribose-5-phosphate to pseudouridine in stoichiometric amounts. The addition of the nucleotidase inhibitor sodium arsenate altered the course of the reactions involved in such a way that pseudouridylic acid became the product. Under these conditions, the latter was formed in the same relative concentrations as pseudouridine in experiments without inhibitor.The direct synthesis of pseudouridylic acid from the above precursors was found to be catalyzed by an enzyme which has been tentatively designated as "pseudouridylic acid synthetase". This enzyme was separated from the nucleotidase and purified 80-fold. Parameters such as pH optimum, required ion concentration, and Michaelis constants were determined.The data presented in this paper permit the first description of the biosynthetic pathway for pseudouridylic acid and for pseudouridine in a bacterium.
Pseudouridine, the fifth-most abundant nucleoside in RNA, is not metabolized in mammals, but is excreted intact in urine. The purpose of the present work was to search for an enzyme that would dephosphorylate pseudouridine 5′-phosphate, a potential intermediate in RNA degradation. We show that human erythrocytes contain a pseudouridine-5′-phosphatase displaying a Km ≤ 1 μM for its substrate. The activity of the partially purified enzyme was dependent on Mg2+, and was inhibited by Ca2+ and vanadate, suggesting that it belonged to the ‘haloacid dehalogenase’ family of phosphatases. Its low molecular mass (26 kDa) suggested that this phosphatase could correspond to the protein encoded by the HDHD1 (haloacid dehalogenase-like hydrolase domain-containing 1) gene, present next to the STS (steroid sulfatase) gene on human chromosome Xp22. Purified human recombinant HDHD1 dephosphorylated pseudouridine 5′-phosphate with a kcat of 1.6 s−1, a Km of 0.3 μM and a catalytic efficiency at least 1000-fold higher than that on which it acted on other phosphate esters, including 5′-UMP. The molecular identity of pseudouridine-5′-phosphatase was confirmed by the finding that its activity was negligible (<10% of controls) in extracts of B-cell lymphoblasts or erythrocytes from X-linked ichthyosis patients harbouring a combined deletion of the STS gene (the X-linked ichthyosis gene) and the HDHD1 gene. Furthermore, pseudouridine-5′-phosphatase activity was 1.5-fold higher in erythrocytes from women compared with men, in agreement with the HDHD1 gene undergoing only partial inactivation in females. In conclusion, HDHD1 is a phosphatase specifically involved in dephosphorylation of a modified nucleotide present in RNA.